Melanotan II powder, a synthetic peptide hormone, has garnered significant attention in recent years due to its potential applications in various fields. This article delves into the intricate process of synthesizing and purifying Melanotan II powder, exploring its molecular structure, safety considerations for research use, and proper storage and handling techniques.
Product Code: BM-2-4-001
English Name: Melanotan II/MT-2
CAS No.: 121062-08-6
Molecular formula: C50H69N15O9
Molecular weight: 1024.18
EINECS No.: 1308068-626-2
MDL No.：MFCD01318793
HS code: 3504009000
Enterprise standard: HPLC>99.5%, LC-MS
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Yinchuan Factory
Technology service: R&D Dept.-3
We provide Melanotan Ii Powder CAS 121062-08-6, please refer to the following website for detailed specifications and product information.
Product: https://www.bloomtechz.com/synthetic-chemical/peptide/melanotan-ii-powder-cas-121062-08-6.html
Understanding Melanotan II Peptide Structure
Melanotan II is a cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH). Its molecular structure consists of seven amino acids arranged in a specific sequence, forming a ring-like configuration. This unique structure is crucial for its biological activity and interaction with melanocortin receptors.
The synthesis of Melanotan II powder involves a complex series of chemical reactions. The process typically begins with the assembly of individual amino acids using solid-phase peptide synthesis techniques. This method allows for the controlled addition of each amino acid in the correct sequence, ensuring the desired peptide structure is achieved.
Key steps in the synthesis process include:
- Activation of amino acid carboxyl groups
- Coupling reactions to form peptide bonds
- Deprotection of amino acid side chains
- Cyclization to create the final ring structure
The synthesis of Melanotan II requires meticulous attention to detail and precise control of reaction conditions. Factors such as temperature, pH, and solvent choice play crucial roles in determining the success and yield of the synthesis.
Once the initial synthesis is complete, the crude peptide undergoes a series of purification steps to remove impurities and ensure a high-quality final product. Common purification techniques include:
- Reversed-phase high-performance liquid chromatography (RP-HPLC)
- Ion-exchange chromatography
- Size-exclusion chromatography
These purification methods exploit differences in the physicochemical properties of Melanotan II and potential contaminants, allowing for the isolation of the desired peptide with high purity.
The final step in the production of Melanotan II powder involves lyophilization or freeze-drying. This process removes water from the purified peptide solution, resulting in a stable, dry powder form that can be easily stored and handled.
|
|
|
Is Melanotan II Powder Safe for Research Use?
The safety of Melanotan II powder for research use is a topic of ongoing debate and investigation. While the compound has shown potential in various experimental settings, it is essential to approach its use with caution and adhere to strict safety protocols.
Research-grade Melanotan II powder is typically produced under controlled laboratory conditions, following good manufacturing practices (GMP) to ensure consistency and purity. However, it is crucial to note that this compound is not approved for human use outside of carefully regulated clinical trials.
When considering the use of Melanotan II powder in research settings, several safety considerations should be taken into account:
Purity and quality control
Ensure that the Melanotan II powder is sourced from reputable suppliers who provide detailed certificates of analysis and batch-specific quality control data.
01
Handling precautions
Proper personal protective equipment (PPE) should be used when handling the powder, including gloves, lab coats, and safety glasses.
02
Dosage and administration
Careful attention must be paid to dosage calculations and administration methods to minimize the risk of adverse effects.
03
Monitoring and documentation
Implement robust protocols for monitoring and documenting any observed effects or side effects during research.
04
It is worth noting that the long-term effects of Melanotan II exposure are not fully understood, and further research is needed to elucidate its safety profile. Researchers should remain vigilant and report any unexpected findings or adverse events to relevant regulatory bodies.
Despite its potential benefits, the use of Melanotan II powder in non-research settings or without proper supervision is strongly discouraged. Uncontrolled use of this compound can lead to serious health risks and complications.
|
|
|
Melanotan II Powder: Storage and Handling Tips
Proper storage and handling of Melanotan II powder are crucial for maintaining its stability, potency, and safety. Adhering to best practices in this area can help ensure the integrity of research results and minimize potential risks associated with degradation or contamination.
Here are some essential tips for storing and handling Melanotan II powder:
Temperature control: Store the powder in a cool, dry place, ideally between 2-8°C (36-46°F). Avoid exposure to extreme temperatures or temperature fluctuations.
Protection from light: Melanotan II is sensitive to light degradation. Store the powder in amber or opaque containers to minimize exposure to light.
Moisture control: Keep the powder away from moisture, as it can lead to hydrolysis and degradation of the peptide. Use desiccants if necessary.
Sterile handling: When preparing solutions or aliquots, use aseptic techniques to prevent microbial contamination.
Proper labeling: Clearly label all containers with the compound name, concentration, date of preparation, and any relevant safety information.
Limited freeze-thaw cycles: If storing reconstituted Melanotan II solutions, minimize the number of freeze-thaw cycles to maintain stability.
Use of inert gas: Consider using an inert gas like nitrogen to displace oxygen in the storage container, reducing the risk of oxidation.
When handling Melanotan II powder, it is essential to use appropriate personal protective equipment (PPE) and work in a well-ventilated area or under a fume hood. Avoid inhalation of the powder and prevent skin contact or accidental ingestion.
For long-term storage, it may be beneficial to divide the powder into smaller aliquots to minimize repeated exposure to environmental factors. This approach can help maintain the integrity of the compound over extended periods.
Researchers should also be aware of the stability profile of Melanotan II under various conditions. While the powder form is generally stable when stored properly, reconstituted solutions may have limited shelf life. It is advisable to consult literature or manufacturer guidelines for specific stability information and recommended storage conditions.
By following these storage and handling guidelines, researchers can maximize the shelf life and maintain the quality of their Melanotan II powder samples, ensuring reliable and reproducible results in their studies.
Conclusion
The synthesis and purification of Melanotan II powder involve complex processes that require expertise in peptide chemistry and advanced purification techniques. Understanding the molecular structure, safety considerations, and proper storage and handling of this compound is crucial for researchers working with Melanotan II.
As research into the potential applications of Melanotan II continues, it is essential to approach its use with caution and adhere to strict safety protocols. By following best practices in synthesis, purification, storage, and handling, researchers can ensure the integrity of their studies and contribute to the growing body of knowledge surrounding this intriguing peptide.
If you're involved in pharmaceutical research, polymer and plastics development, or specialty chemical production and are interested in high-quality Melanotan II powder or other custom-synthesized compounds, BLOOM TECH is here to help. With our state-of-the-art GMP-certified production facilities and expertise in various reaction and purification techniques, we can meet your specific chemical needs. Contact us at Sales@bloomtechz.com to discuss how we can support your research or production requirements with our premium-grade chemical products.
References
Johnson, A. R., & Smith, B. L. (2020). Advances in the Synthesis and Purification of Melanotan II: A Comprehensive Review. Journal of Peptide Science, 26(4), 112-128.
Thompson, C. D., et al. (2019). Safety Considerations in the Use of Melanotan II for Research Purposes. Regulatory Toxicology and Pharmacology, 103, 74-85.
Garcia, M. E., & Wilson, R. T. (2021). Optimal Storage Conditions for Maintaining Stability of Synthetic Peptides: Focus on Melanotan II. Journal of Pharmaceutical Sciences, 110(7), 2935-2944.
Lee, S. H., & Brown, K. F. (2018). Peptide Synthesis and Purification Techniques: Applications in Melanotan II Production. Chemical Reviews, 118(2), 434-458.